Extracellular ATP promotes cancer cell drug resistance to tyrosine kinase inhibitors by competing for the ATP-binding site of tyrosine kinase

被引：0
|
作者：
Wang, Xuan [1 ]
Qian, Yanrong [1 ]
Li, Yunsheng [1 ]
Chen, Xiaozhuo [1 ]
机构：
[1] Ohio Univ, Athens, OH 45701 USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-5462
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5462
引用
收藏
页数：1
相关论文
共 50 条
  • [1] THE ATP-BINDING SITE - A TARGET FOR THE RATIONAL DESIGN OF SELECTIVE TYROSINE KINASE INHIBITORS
    TRAXLER, PM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 143 - MEDI
  • [2] Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance
    Wang, Yi-Jun
    Zhang, Yun-Kai
    Kathawala, Rishil J.
    Chen, Zhe-Sheng
    CANCERS, 2014, 6 (04): : 1925 - 1952
  • [3] Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family
    Olivero, M
    Valente, G
    Bardelli, A
    Longati, P
    Ferrero, N
    Cracco, C
    Terrone, C
    Rocca-Rossetti, S
    Comoglio, PM
    Di Renzo, MF
    INTERNATIONAL JOURNAL OF CANCER, 1999, 82 (05) : 640 - 643
  • [4] ATP-binding Cassette Transporter Inhibition by Tyrosine Kinase Inhibitor Nilotinib
    Quint, K.
    Di Fazio, P.
    Montalbano, R.
    Lingelbach, S.
    Ocker, M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S248 - S248
  • [5] Comparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and Dasatinib
    Dohse, Marius
    Scharenberg, Christian
    Shukla, Suneet
    Robey, Robert W.
    Volkmann, Thorsten
    Deeken, John F.
    Brendel, Cornelia
    Ambudkar, Suresh V.
    Neubauer, Andreas
    Bates, Susan E.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (08) : 1371 - 1380
  • [6] Molecular docking exploration of potential RET tyrosine kinase inhibitors at non ATP-binding sites.
    Nicolescu, Adrian C.
    Gujral, Taranjit S.
    Zelt, Jordan D. S.
    Mulligan, Lois M.
    CANCER RESEARCH, 2013, 73 (08)
  • [7] Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase
    Pflug, Alexander
    de Oliveira, Taiana Maia
    Bossemeyer, Dirk
    Engh, Richard A.
    BIOCHEMICAL JOURNAL, 2011, 440 : 85 - 93
  • [8] c-MET tyrosine kinase inhibitors reverse drug resistance mediated by the ATP-binding cassette transporter B1 (ABCB1) in cancer cells
    Nazari, Somayeh
    Poustforoosh, Alireza
    Paul, Priyanka Rani
    Kukreti, Ritushree
    Tavakkoli, Marjan
    Saso, Luciano
    Firuzi, Omidreza
    Moosavi, Fatemeh
    3 BIOTECH, 2025, 15 (01)
  • [9] Tyrosine kinase inhibitors .10. Isomeric 4-[(3-bromophenyl)amino]pyrido[d]-pyrimidines are potent ATP-binding site inhibitors of the tyrosine kinase function of the epidermal growth factor receptor
    Rewcastle, GW
    Palmer, BD
    Thompson, AM
    Bridges, AJ
    Cody, DR
    Zhou, HR
    Fry, DW
    McMichael, A
    Denny, WA
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (09) : 1823 - 1835
  • [10] A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase
    Klingbeil, CK
    Gill, GN
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 363 (01) : 27 - 32
12345